"Feeling seen, appreciated, and emotionally supported is not a luxury feature in health AI - it is a condition of access," ...

Novo Nordisk has become the latest pharma group to be targeted by a cyberattack, with the company revealing that some patient ...

Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

Zasocitinib – which is billed by Takeda as a second-generation TYK2 inhibitor – was more effective than Sotyktu ...

The Stem research and interviews with senior Centre of Excellence (CoE) leaders at Boehringer Ingelheim, Takeda, Merck, Novo ...

AI company Anthropic has launched a new large language model (LLM) – Claude Fable 5 – claiming its capabilities as a tool for ...

mRNA-4194 is drawing on Moderna's cancer vaccine platform, headed by melanoma candidate intismeran autogene (mRNA-4157), ...

Fueled by this momentum, the 16th World Clinical Biomarkers & Companion Diagnostics Summit makes its return to Boston, with ...

But it’s also important to think about the quality of that life. In a conversation with pharmaphorum Editor in Chief Jonah ...

San Francisco-based SonoThera closed an oversubscribed $125 million Series B financing round, saying it will use the proceeds ...

Takeda presented data across a range of therapeutics and indications at ASCO 2026, including on investigational drugs like ...

Radiotherapeutics were a major topic at ASCO this year, as more and more studies progress on a variety of targets, isotopes, ...